Home About Us Contact Us

 

Table of Content - Volume 1 Issue 2 - February 2016


 

Clinical profile of lung cancer patients

 

Bharate Ramesh Tukaram1*, D G Mhaisekar2, Anil Maske3

 

1Associate professor and head Dept of chest and TB Govt medical college, Latur, Maharashtra, INDIA.

2Professor and HOD, Department of Chest and TB, Government Medical College Nanded, Maharashtra, INDIA.

3Lecturer, SRTR medical college, Ambajogai, Maharashtra, INDIA.

Email: rameshbharate@gmail.com          .

 

Abstract              Background: lung cancer is a fatal cancer. In countries like India the incidence and mortality rates show a rising trend. It is having poor prognosis. Clinical presentation of patients vary in almost all cases. Aim and Objective: To study clinical profile of patients with primary lung malignancies. Material and Methods: study was carried out in 58 indoor patients, who were having high index of clinical, radiological suspicion of carcinoma of lung. All patients were studied for history, clinical examination, routine blood investigations and selected patients underwent other diagnostic methods. Results and Discussion: Male urban to rural ratio was 1:2.8 while female urban to rural ratio was 1:6.5.Chest pain (91.37%), cough (74.13%), breathlessness (72.41%), Anorexia (53.44%), Weight loss (44.82%) and Haemoptysis (20.68%) were common presenting symptoms. Lymphadenopathy (37.93%), clubbing (24.13%), superior vena cava obstruction (18.96%) were common clinical features. Conclusion: Age of 50 yrs or more and male sex is a risk factors for lung cancer. squamous cell carcinoma was predominent in followed by adenocarcinoma. Chest pain is the commonest symptom. Tobacco smoking of 20 pack years or more is significantly associated with an increase in the incidence of lung cancer.

Key Words: lung cancer, chest pain.                                          

 

INTRODUCTION

Cancer is a Latin word meaning "A CRAB". The Greek word for a crab is "KARKINES" and Sanskrit word is "KARKARA1. Lung cancer is regarded by the World Health Organization as a leading cause of death globally. Various risk factors have been implicated for the rising trends in lung cancer. Cigarette tobacco smoking is by far the world's commonest cause. Overall survival for a diagnosed case of lung cancer is not more than 5 yrs and it is only 5-10%. In countries like India the incidence and mortality rates show a rising trend. Lung cancer is most common in males in all urban registries. The life time risk (30-74 yrs) of developing lung cancers varies widely. In developed countries alone it ranges from 3-14% in males and less than 1% to 10% in females2. The clinical presentation usually depends on the location, extent of tumour. The prognosis ultimately depends on the tumour histology, staging, type of treatment used and the performance status of the patient. Limited data are available on lung cancer epidemiology in India. This study aimed to determine the profile of patients with lung cancer who were seen at a tertiary hospital.

 
MATERIAL AND METHODS
This study was carried out in 58 indoor patients, who were having high index of clinical, radiological suspicion of carcinoma of lung during the period Janury 2000 to March 2002, at tertiary care hospital.
Inclusion Criteria: Patients with positive end diagnosis of lung carcinoma proved by Histo pathological examination.

Exclusion Criteria:

  1. Secondaries in the lung from a known primary.
  2. Diagnosis could not be proved histopathologically.
  3. Patients not willing for diagnostic procedure.

Pre tested questionnaire was used to collect data from the patients. It includes Nourishment

Body weight, Clubbing, Pallor, Hypertrophic pulmonary osteoarthropathy, Lymphadenopathy – sites, Signs of superior vena cava obstruction, Nerulogical deficit. And Extra pulmonary metastatic and non metastatic manifestations. Investigations like Haemogram, BSL, BUL, LFT, Urine, Serum Electrolytes, Bleeding time, clotting time and prothrombine time, Blood grouping and cross matching were done. Investigations for lung cancer were Sputum, X-ray Chest Ultra sonography of Chest done in all cases. In selected cases ECG, USG - Abdomen (liver metastasis), Fibre Optic Bronchoscopy were done. Special investigations to demonstrate presence of metastasis were done only when, the symptoms were suggestive of metastasis in particular organ.


 

RESULTS

 

Table 1: Distribution of patients according to age and sex

Age Group in years

No.of patients

Total

Percentage

 

Male

Female

 

 

21-30

4(9.30%)

2(13.33%)

6

10.34%

31-40

2(4.65%)

4(26.66%)

6

10.34%

41-50

6(13.95%)

5(33.33%)

11

18.96%

51-60

16(37.20%)

1(6.66%)

17

29.31%

61-70

13(30.23%)

3(20.00%)

16

27.58%

71-80

1(2.32%)

--

1

1.72%

81-90

1(2.32%)

--

1

1.72%

Total and Percentage

43(74.13%)

15(25.86%)

58

 

 

Table 2: Incidence (frequency) of various symptoms in cases of lung cancer

Symptoms

No.of patients

Percentage

Chest pain

53

91.37

Cough

43

74.13

Breathlessness

42

72.41

Anorexia

31

53.44

Weight loss

26

44.82

Fever

18

31.03

Haemoptysis

12

20.68

Dysphagia

8

13.79

Hoarseness of voice

9

15.51

Asymptomatic

3

5.17

Bone pain

3

5.17

Swelling over face

2

3.44

 

Table 3: Distribution of patients according to sign's observed due to metastatic and nonmetastatic manifestations

 

Signs

No. of patients

Percentage

General

Clubbing

14

24.13%

Hypertrophic pulmonary osteoarthropathy

3

5.17%

L.N. Pathy

22

37.93%

Horner's syndrome

3

4.17%

Skin nodules and pigmentation

2

3.44%

SVCS

11

18.96%

Pancoast's syndrome

2

3.44%

Systemic

Pleural effusion

27

46.55%

Vocal cord palsy (laryngeal nerve involvement)

5

8.62%

Diaphragmatic paralysis (Phrenic nerve involvement)

2

3.44%

Liver involvement

10

17.24%

CNS involvement

2

3.44%

 

 

Table 4: Distribution of patients according to smoking habits

Smoker

Non smoker

Male

(%)

Female

(%)

Total

(%)

Male

(%)

Female

(%)

Total

(%)

27

0

27

16

15

31

(46.55%)

(0%)

(46.55%)

(51.61%)

(48.38%)

(53.44%)

 

Table 5: Distribution of patients according to duration of smoking and type smoked

Bidis / Cigarettes

No.of patients smoked for a period of

<10 yrs

11-20 yrs

21-30 yrs

>30 yrs

Total

Percentage

Bidis

0

4

11

4

19

70.37%

Cigarettes

0

2

2

0

4

14.81%

Bidis + Cigarettes

0

2

2

0

4

14.81%

Total

0

8

15

4

27

 

 

Table 6: Distribution of patients according to Histological classification of lung malignancies

Type

No. of patients

Percentage

Squamous cell carcinoma

24

41.37%

Adenocarcinoma

15

25.86%

Small cell carcinoma

9

15.51%

Unclassified carcinoma

9

15.51%

Others

1

1.72%

 


It was observed that out of 58 cases, 43 (74.13%) cases were males and 15 (25.86%) cases were females. Males outnumbered the females and the male to female ratio was 2.86:1. The age of the patients ranged from 23 to 85 years. The maximum number 17 (29.31) patients were in the age group of 51-60. Amongst the remaining cases, 6 patients (10.34%) were below 30 yrs of age and 29.31% patients were above the age of 60 yrs (Table 1). Most of the patients (75.86%) were from rural area and only 24.13) were from urban area. Male urban to rural ratio was 1:2.58 while female urban to rural ratio was 1:6.5. Most of the cases were having chest pain (91.37%). The other symptoms observed in descending order of incidence were cough in 74.13%, Breathlessness in 72.41% Anorexia in 53.44%, weight loss in 44.82%, fever in 31.03%, Haemophysis in 20.68%, Dysphagia in 13.79%, Hoarseness of voice in 15.51%, Asymptomatic 5.17%, Bone pain in 5.17% and Swelling over face in 3.44% of the cases (Table 2). Most of the patients (55.17%) had duration of disease less than 1 month, and 31.02% cases had more than 2 months duration. Out of 58 cases, General practitioner referred 26 patients between 1-4 months of duration after the onset of symptoms. Amongst them 13 (22.41%) patients had received anti tuberculous treatment and were treated empirically as pulmonary tuberculosis. Average time of reaching the diagnosis after the onset of symptoms was 2-3 months. It was observed that, maximum No. of cases presented with metastatic stage. Amongst them pleural effusion was in 46.55% cases, lymphnode enlargement in 37.93%, clubbing in 24.13%, superior vena cava obstruction in 18.96%, Liver involvement in 17.24%, and Vocal cord palsy was seen in 8.62% cases. Pancost's syndrome was seen in only 3.44%. Remaining patients presented with Horner's syndrome 4.17%, skin nodules and pigmentation in 3.44% respectively. Only two patients (3.44%) one each presented with convulsions and paraplegia respectively Suggestive of CNS involvement (Table 3). It was observed that out of 58 patients 31(53.44%) patients never smoked. All females and 16 males were non smokers. 27 males (46.55%) were smokers. It was observed that 15 patients (55.55%) were having high index smoking for more than 21-30 yrs. While 8 patients (29.62%) were smoking for 11-20 yrs. Rest of the patients (14.81%) had history of smoking for more than 30 yrs (table 4and 5). All patients were investigated for sputum for malignant cells. It was found that only 4 cases (6.89%) showed positivity for malignant cell. Remaining (93.10%) showed negativity for malignant cell. It was observed that out of 58 patients, squamous cell carcinoma was predominent in 41.37% cases; followed by adenocarcinoma in 25.86% cases, small cell carcinoma in 15.51% cases, and unclassified carcinoma in 15.51% cases. Non hodgekin's lymphoma was seen in one (1.72%) case (Table 6).

 

DISCUSSION

In the present study patients age ranged from 23 to 85 yrs. The majority of cases (29.31%) were in the age group of 51-60 yrs. this study showed a male to female ratio of 2.86:1. Similar results were observed in Parsey study (1964)3 where mean incidence of age was4th - 5th decade with male to female ratio of 5:1in P.N. Chhajed et al (1999)4 showed mean age incidence in 5th -6th decade. Male to female ratio was 4.2:1. In S.D. Maasdrop et al2015)5 the ratio was 3:1. In the present series, there was a higher incidence of bronchogenic carcinoma in patients from rural areas. Male urban to rural ratio was 1:2.8. Female urban to rural ratio was 1:6.5 This showed that incidence of lung cancer is increasing in rural area. However Jindal et al (1982)6 observed equal No. of rural and urban dwellers in their series. Most of the cases (91.37%) were having chest pain. However J. S. Guleria et al (1970)7 found only 42.25%. In B.O.Tayade et al (1994)8 75% patients complaints of chest pain. Dry cough was second commonest symptom encountered in present study. It was present in 43 (74.13%). It was not related to any particular time or posture. Jindal et al (1982)6 reported 88% patients having cough, P.N. Chhajed et al (1999)4 reported 61% patients presenting with cough. Breathlessness was present in 42 (72.41%) patients. The most common cause was massive pleural effusion with collapse and underlying lung lesion. Breathlessness was mostly seen in squamous cell carcinoma. W.K.Lam et al (1983)10 described breathlessness to be the commonest symptom in patients with adenocarcinoma. Weight loss was complained by 26 (44.82%) similar results were observed in P.N.Chhajed et al (1999)4 in Mishra et al (2016)(11Anorexia (65.8%) and Weight loss (57.9%) were the commonest general symptoms and more commonly seen among older age groups (61-80 yrs) and (>80yrs) Haemoptysis in this series was seen in 12(20.68%) patients. Presentation was with blood streaked sputum, but massive haemoptysis was not encountered. Haemoptysis was found in patients with squamous cell carcinoma. This could be explained by the frequent occurrence of squamous cell carcinoma in central location, its tendency to cavitate or form lung abscess. Frequency of haemoptysis found in other studies were 61%in Le Roux et al (1968)12 24 % in P.N. Chhajed et al (1999)4 The duration of disease was estimated by the time interval between onset of first symptoms and admission to the hospital. Maximum No. of cases (55.17%) had less than one month of their symptoms. General practitioner referred 18 cases between 2-4 months for further investigations. 32 patients were diagnosed in less than one month at the specialist level. Amongst 58 patients, 50(86.20%) were diagnosed within 2-3 of their symptoms and 54 (93.10%) were diagnosed within 6 months of their symptoms. Remaining 4 patients took more than 6 months for their diagnosis. Amongst the 58 patients, 13 patients were receiving antitubercular chemotherapy on the basis of radiological lesion for a variable periods of 1-6 months. Average time in reaching a diagnosis in different study is: Buchsery et al (1975)13 in 1-5 month and Oschner et al (1956)14 in 12-30 month. Clubbing was seen in 14 (24.13%) of cases. Most frequently seen in squamous cell carcinoma (64.28%), followed by small cell carcinoma (21.42%) and adenocarcinoma (14.28%). Clubbing was mostly grade III or IV. Leroy Hyde et al (1974)15 observed clubbing most frequently in squamous cell carcinoma. Hypertrophic pulmonary osteoarthropathy was seen in 3(5.17%) patients of squamous cell carcinoma. However Chhajed et al (1999)4 found hypertrophic pulmonary osteoarthropathy in only one patient who had a pathological diagnosis of adenocarcinoma. Ya Couh M.H. et al (1965)16 found 4-12% of patients of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma. Commonly distal segments of shafts of long bones were affected (Knoles J.H. et al 1960)17 described HPOA, in 2% of patients with squamous cell carcinoma, 0.7% patients with adenocarcinoma, 9% patient with large cell carcinoma. HPOA was not found in small cell carcinoma in present study. Lymphadenopathy was present in 37.93% of patients. All patients presented with significantly enlarged, hard, fixed, non tender, supraclavicular, and cervical Lymphnode Leroy Hyde et al (1974)15 found 15-20% of patients during the course of lung cancer. P. N. Chhajed et al (1999)4 found 42.5% lymph node metastasis, most common in squamous cell carcinoma. In present series the findings are similar to P.N. Chhajed group.  The incidence superior vena cava syndrome in our study was 11 (18.96%). In our study it was most commonly seen in small cell carcinoma (36.36%) followed by squamous cell carcinoma (27.27%) and adenocarcinoma (27.27%). In veteran administration study series (Leroy Hyde et al 1974)65 SVCS was present in 4% cases. Lam et al (1986)10 also described SVC syndrome to be most common in small cell carcinoma (18%). Pleural effusion was seen in 27(46.55%) patients. In our study it was most commonly seen in squamous cell carcinoma (29.62%) and unclassified carcinoma (29.62%) followed by small cell carcinoma. Guleria et al (1975)7 reported 22.22% incidence of pleural effusion in lung cancer. P.N.Chhajed et al (1999)4 reported 23.3% incidence and adenocarcinoma as the main cause. Vocal cord paralysis was seen in 5 (8.62%) patients. N.K.Jain et al (1989)18 reported incidence of 9% in their study. P.N.Chhajed et al (1999)4 reported 13.7% incidence. Recurrent laryngeal nerve involvement was only seen in central tumours in all our patient. In our study the incidence of liver involvement was 10(17.24%). Leory Hyde et al (1974)15 reported lung cancer metastasis to liver in 35% cases. In our study liver metastasis was commonest in adenocarcinoma (60%). P.N.Chhajed et al (1999)4 reported 17% incidence of liver metastasis, 30% squamous cell carcinoma and 65% of small cell carcinoma type. CNS involvement was seen in 2 (3.44%) cases. These patients presented with convulsions and paraplegia. Lam et al (1983)10 reported 4% incidence of CNS involvement. P.N.Chhajed et al (1999)4 in their study reported 9.6% incidence and most commonly in small cell carcinoma (42.9%). In our study the smoker to non smoker ratio was 0.86:1. Other studies showed similar incidence like Jha et al (1972)19 where ratio was 0.9:1 and P.N.Chhajed et al (1999)4 with ratio of 2.17:1. In our study Bidi smokers (70.37%) were outnumbered than cigarette smokers. V.K.Jha (1972)19, found a lung cancer ratio of 1.4:1 among rural male and female smokers. D. Behera (1992)20 concludes that the risk of lung cancer is reported to be higher in Bidi smokers than cigarette smokers. In our study maximum smokers had duration of smoking more than 20-30 yrs. (55.55%). In S.D. Maasdrop et al (2015) Most werecurrent or previous smokers and 31 (33.7%) had a smoking history of at least 30 pack years.

 

CONCLUSION

Age of 50 yrs or more and male sex are still a risk factors for lung cancer. Tobacco smoking of 20 pack years or more is significantly associated with an increase in the incidence of lung cancer in rural males. The relatively non availability of smokeless and fully combustible fuels for domestic use to rural females accounted for greater number of lung cancer in rural females than urban females.

 

REFERENCES

  1. Bhende Y.H.: General pathology, Vol. II, 5th Edn. 1994,. Page 665.
  2. B. B. Yeole – An epidemiological assessment of lung cancer in India Napcon. Nov. 2001, Page. 184.
  3. A. M. Washington, Robert Buchiley : Further evidence on a proposition by Prof. Passey. Lancet July 1964; P. 36-40.
  4. P. N. Chhajed et al: Clinical and pathological profile of 73 patients with lung carcinoma. JAPI, 1999.
  5. Jindal S. K., Malik S.K., Gujral J. S. et al: Bronchogenic carcinoma in Northern India. Thorax 37: 343-47, 1982
  6. Guleria J. S., Gopinath N., Talwar J. R., Bhargava S., Pande J. N., Gupta K. G. : Bronchogenic carcinoma - an analysis of 120 cases. J. Assoc. Physicians Ind. 18, : 251-254, 1971.
  7. B. O. Tayade : Study of superior vena cava syndrome aetiopathology, diagnosis and management. JAPI 1994, Vol. 42, No. 8.
  8. William Umiker : Relative accuracy in diagnosis of carcinoma of lung. JAMA 1966; 195/8: 145-50.
  9. Mishra
  10. Le Roux B.T. : Bronchial carcinoma. Edinburgh, London, E. and S. Livingstone, 1968.
  11. Buccheri G., Barberis P., Delfins M: Diagnostic Morphologic and histopathologic corelates in Bronchogenic carcinoma. Chest 99: 809-14, 1991.
  12. Oshner A : Surgery of diseases of Lung. Postgrad. Med. 19: 584, 1956
  13. Leroy Hyde and Charles Hyde. : Clinical manifestation of lung cancer. Chest, 65: 3, March 1974.
  14. Zavala C., Richardon R., Mukerjee P.: Use of bronchofiberscope for bronchial brush biopsy. Chest 63: 889-92, 1979.
  15. Knowles J. H. et al: Extrapulmonary manifestations of bronchogenic carcinoma. N. Engl. J. Med. 262: 505, 1960.
  16. Jain N. K., Madan A., Sharma T.N., Saxena A. : J. Assoc. Physicians India. 37: 379-82, 1989.
  17. Jha V. K. Ray D. C., Ravindran P. : Bronchogenic Carcinoma - A clinicopathological study. Ind. J. Chest Diseases. 14: 78-85, 1972.
  18. Behera D. : Lung cancer in India. J. Chest Dis. and Allied Sci. 1992; 34, No. 2: 91-101.

 


 

 

 



 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.